EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
Clinical trials for EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for kids with tough TB: new drug combo under study
Disease control Recruiting nowThis study is testing a medicine called bedaquiline, given together with other TB drugs, in children and teens (from birth to under 18 years) who have multidrug-resistant tuberculosis (MDR-TB) of the lungs. The goal is to see how safe the drug is, how the body processes it, and w…
Matched conditions: EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 17, 2026 02:42 UTC
-
TB study seeks volunteers to help scientists uncover disease secrets
Knowledge-focused Recruiting nowThis study aims to learn more about tuberculosis (TB) by collecting blood, sputum, and skin samples from people with active or latent TB. Researchers will follow participants over time to track how the disease progresses and how the body responds. The goal is to improve understan…
Matched conditions: EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC